INTERNATIONAL PATENT: IMMORTA BIO, INC. FILES APPLICATION FOR "PLURIPOTENT STEM CELL DERIVED MESENCHYMAL STEM CELLS WITH ENHANCED IMMUNE MODULATORY ACTIVITY"

GENEVA, Nov. 19 -- IMMORTA BIO, INC. (7064 Fisher Island DriveMiami Beach, Florida 33109) filed a patent application (PCT/US2025/028946) for "PLURIPOTENT STEM CELL DERIVED MESENCHYMAL STEM CELLS WITH ENHANCED IMMUNE MODULATORY ACTIVITY" on May 12, 2025. With publication no. WO/2025/235998, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ICHIM, Thomas E. (c/o Immorta Bio, Inc.7064 Fisher Island DriveMiami Beach, Florida 33109), REZNIK, Boris (c/o Immorta Bio, Inc.7064 Fisher Island DriveMiami Beach, Florida 33109), RAMOS, ...